Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel two-step synthesis method for Fenofibrate Impurity G ensures high purity and cost-effective supply chain solutions for pharmaceutical quality control.
Novel 5-step synthesis of KRAS G12D inhibitor intermediate 1 from L-proline. Reduces cost and complexity compared to ozonolysis routes.
Patent CN102070490B reveals a novel route for fexofenadine intermediates, offering high purity and significant cost reduction in API manufacturing for global supply chains.
Patent CN115894503A details a streamlined 5-step synthesis of a key pyrrolizine intermediate from L-proline, offering significant cost reduction and safer processing for API manufacturing.
Patent CN101519384A details a one-step synthesis of chiral oxazolines. Offers high enantioselectivity for asymmetric catalysis and scalable manufacturing solutions.
Patent CN108912055B details a catalytic asymmetric dihydroxylation route for antiviral intermediates, offering cost-effective and scalable manufacturing solutions for global supply chains.
Patent CN113754600A reveals a safer, cost-effective route for 1,4-diazaspiro[5,5]undecan-3-one, eliminating toxic reagents for reliable pharmaceutical intermediate supply.
Patent CN111170924B reveals a mild electrochemical route for fluorinated indoles, offering cost-effective scale-up for pharmaceutical intermediates.
Patent CN112552184B reveals a scalable 4-step synthesis for cyclopropyl chiral amines, offering significant cost reduction and high purity for pharmaceutical manufacturing.
Novel synthesis method for Bortezomib intermediates ensures high purity and cost efficiency. Reliable supply chain for pharmaceutical manufacturing partners seeking scalable solutions.
Patent CN116554056A reveals a novel one-pot base-catalyzed synthesis for high-purity cyclohexane intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN110903189B details a cost-effective copper-catalyzed route for chiral 2-aryl propionates, offering significant supply chain advantages for NSAID intermediate manufacturing.
Patent CN102633802B details a scalable 3-step route for 2-chloro-7H-pyrrolo[2,3-d]pyrimidine, offering significant cost reduction and simplified purification for API manufacturing.
Patent CN112047829B reveals a cost-effective Grignard carboxylation route for high-purity Alectinib intermediates, offering significant supply chain advantages.
Novel patent CN108623577A offers high-yield Amonebvir intermediate synthesis. Reduces steps, avoids protecting groups, ensures supply chain stability for pharmaceutical manufacturing.
Patent CN106380466B details a high-purity cobalt-catalyzed route. Offers supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing globally.
Patent CN101319236A details a green biocatalytic method for chiral alcohols using ionic liquids. Achieve high purity and cost reduction in pharma intermediate manufacturing with scalable processes.
Patent CN116554056A reveals a novel one-pot base-catalyzed route for cyclohexane derivatives, offering significant cost reduction in fine chemical manufacturing and high-purity outcomes.
Patent CN113429349B details a novel Cu/g-C3N4 catalyzed route for 2-trifluoromethyl benzimidazoles, offering mild conditions and recyclable catalysts for cost-effective manufacturing.
Novel biocatalytic route for chiral alcohol intermediates ensures >99% ee and scalable production for beta-3 agonists.